clofibrate has been researched along with colestipol in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 51 (89.47) | 18.7374 |
1990's | 5 (8.77) | 18.2507 |
2000's | 1 (1.75) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heimann, KW; Stein, EA | 1 |
Vogelberg, KH | 1 |
Grundy, SM | 1 |
Levy, RI | 2 |
Baggio, G; Baiocchi, MR; Baldo, G; Briani, G; Crepaldi, G; Fellin, R; Manzato, E | 1 |
Martz, BL | 1 |
Mertz, DP | 1 |
Fleischmajer, R | 1 |
Augustin, J; Greten, H; Klose, G; Middelhoff, G; Mordasini, R | 1 |
Grundy, SM; Mok, HY | 1 |
Fisher, AC; Wallenstein, S | 1 |
Hanefeld, M | 1 |
Phillips, WA; Ratchford, JM; Schultz, JR | 1 |
Fumagalli, R; Sirtori, CR; Torreggiani, D | 1 |
Kudchodkar, B; Nestel, PJ | 1 |
Gotto, AM; Yeshurun, D | 1 |
Kłosiewicz-Latoszek, L; Szostak, WB | 1 |
Counsell, RE; DeForge, LE; DeGalan, MR; McConnell, DS; Schwendner, SW | 1 |
Kane, JP; Malloy, MJ | 1 |
Naito, HK | 1 |
Davignon, J | 1 |
Blum, CB; Levy, RI | 1 |
Nikkilä, EA; Tikkanen, MJ | 1 |
Havel, RJ; Kane, JP | 2 |
Gotto, AM; Jones, PH; Scott, LW | 1 |
Packard, CJ; Shepherd, J | 1 |
Stamler, J | 2 |
Hunninghake, DB; Lin, TL; Peters, J; Probstfield, JL | 1 |
Parker, F | 1 |
Frantz, ID; Hoogwerf, BJ; Hunninghake, DB; Peters, JR | 1 |
Gorman, L; Hunninghake, DB; Probstfield, JL; Statland, BE | 1 |
Albers, JJ; Applebaum-Bowden, D; Gagne, C; Hazzard, WR; Wahl, PW; Warnick, GR | 1 |
Buchwald, H; Fitch, L; Moore, RB | 1 |
Greten, H; Klose, G | 1 |
Coffman, JD; Rasmussen, HM | 1 |
Boberg, J; Hellsing, K; Lithell, H; Vessby, B | 1 |
Freedman, DD; Havel, RJ; Kane, JP; Malloy, MJ; Phillips, NR; Rowe, JS; Tun, P; Williams, ML | 1 |
Berns, L; Eder, HA; Goodman, DS; Seplowitz, AH; Smith, FR | 1 |
Heilman, J; Linden, CV; O'Connell, MJ; Vecchio, TJ | 1 |
Kolb, S; Sailer, D | 1 |
Crow, LO; Hunninghake, DB; Isaacson, SO; Probstfield, JL | 1 |
Bell, C; Hunninghake, DB; Olson, L | 1 |
Albers, JJ; Cheung, MC; Hazzard, WR; Wahl, PW | 1 |
Samuel, P | 1 |
Crouse, JR; Grundy, SM | 1 |
Bambauer, R; Müller, UA; Schiel, R | 1 |
Farmer, JA; Gotto, AM | 1 |
Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M | 1 |
13 review(s) available for clofibrate and colestipol
Article | Year |
---|---|
[Lipid-lowering drugs. Therapeutics and adverse effects].
Topics: Arteriosclerosis; Child; Cholelithiasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Phenoxyacetates; Sitosterols | 1979 |
Treatment of hypercholesterolemia.
Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Diet, Reducing; Dietary Fats; Fats, Unsaturated; Humans; Hypercholesterolemia; Ileum; Intestinal Absorption; Nicotinic Acids; Triglycerides | 1977 |
The effect of hypolipidemic drugs on plasma lipoproteins.
Topics: Aminosalicylic Acid; Animals; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Dogs; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Rats; Sitosterols | 1977 |
Mechanism of action of hypolipidemic drugs.
Topics: Acetoacetates; Animals; Brain; Cholesterol; Clofibrate; Colestipol; Ethanol; Humans; Hydroxybutyrates; Hydroxyindoleacetic Acid; Hyperlipidemias; Liver; Nerve Tissue Proteins; Polyamines; Rats; Triglycerides; Tryptophan | 1975 |
When to treat hyperlipidemia.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Neomycin; Niacin; Pentanoic Acids; Risk Factors; Triglycerides | 1988 |
Reducing cardiac deaths with hypolipidemic drugs.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol | 1987 |
Treatment of hypercholesterolemia.
Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats | 1986 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides | 1986 |
Pharmacological modification of lipoprotein metabolism.
Topics: Animals; Bile Acids and Salts; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Intestinal Absorption; Lipoproteins; Niacin; Sterols | 1987 |
Review of primary prevention trials of coronary heart disease.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dietary Fats; Electrocardiography; Humans; Male; Middle Aged; Physical Exertion; Risk; Smoking Prevention; Stress, Psychological | 1985 |
Therapy of hyperlipidemic states.
Topics: Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Colestipol; Dietary Fats; Drug Therapy, Combination; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipoproteins, LDL; Lipoproteins, VLDL; Niacin; Nicotinic Acids; Sitosterols | 1982 |
Choosing the right lipid-regulating agent. A guide to selection.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Niacin; Triglycerides | 1996 |
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome | 2003 |
13 trial(s) available for clofibrate and colestipol
Article | Year |
---|---|
Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; Placebos; Polyamines; Triglycerides | 1975 |
Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Colestipol; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Polyamines; Time Factors; Triglycerides | 1978 |
Review of primary prevention trials of coronary heart disease.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dietary Fats; Electrocardiography; Humans; Male; Middle Aged; Physical Exertion; Risk; Smoking Prevention; Stress, Psychological | 1985 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone | 1983 |
Overview of randomized clinical trials of lipid intervention for atherosclerotic cardiovascular disease.
Topics: Arteriosclerosis; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Fatty Acids, Unsaturated; Glycine max; Humans; Hypolipidemic Agents; Lipids; Nicotinic Acids; Oils; Random Allocation; Risk; Zea mays | 1982 |
The peripheral circulation and treatment of hyperlipoproteinemias.
Topics: Adult; Aged; Arteriosclerosis Obliterans; Blood Circulation; Clofibrate; Colestipol; Female; Humans; Hyperlipoproteinemias; Intermittent Claudication; Lipids; Male; Middle Aged; Pilot Projects; Polyamines | 1983 |
The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
Topics: Alkaline Phosphatase; Cholesterol; Clofibrate; Colestipol; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hyperlipoproteinemias; Insulin; Male; Middle Aged; Polyamines; Time Factors; Triglycerides; Uric Acid | 1980 |
Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Colestipol; Drug Therapy, Combination; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Nicotinic Acids; Polyamines | 1981 |
Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Colestipol; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Polyamines; Triglycerides | 1981 |
Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
Topics: Adolescent; Adult; Aged; Cholesterol; Clofibrate; Colestipol; Drug Evaluation; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Middle Aged; Polyamines; Triglycerides | 1982 |
High density lipoproteins during hypolipidemic therapy. A comparative study of four drugs.
Topics: Adult; Aged; Aminosalicylic Acid; Apolipoproteins; Cholesterol; Clofibrate; Colestipol; Drug Evaluation; Female; Humans; Hyperlipidemias; Lipoproteins, HDL; Male; Middle Aged; Oxandrolone; Statistics as Topic | 1980 |
Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
Topics: Adult; Aged; Cholesterol; Clofibrate; Colestipol; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Placebos; Polyamines; Random Allocation | 1981 |
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
Topics: Adolescent; Adult; Anticholesteremic Agents; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Longitudinal Studies; Lovastatin; Male; Middle Aged; Niacin; Pravastatin; Quality of Life | 1995 |
32 other study(ies) available for clofibrate and colestipol
Article | Year |
---|---|
Drug management of hypercholesterolemia.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hypercholesterolemia; Nicotinic Acids; Probucol; Sitosterols | 1979 |
[Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view].
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Germany, West; Humans; Hyperlipidemias; Hypolipidemic Agents; Legislation, Drug; Nicotinic Acids; Sitosterols; Thyroxine | 1979 |
Hypolipidemic drugs.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Probucol | 1978 |
[Drug treatment of primary hyperlipoproteinemia (author's transl)].
Topics: Anion Exchange Resins; Biguanides; Cholestyramine Resin; Clofibrate; Colestipol; DEAE-Dextran; Dextrothyroxine; Drug Therapy, Combination; Estrogens; Humans; Hyperlipidemias; Lipoproteins; Neomycin; Nicotinic Acids; Progestins; Sitosterols | 1978 |
Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Topics: Adult; Bile; Bile Acids and Salts; Cholesterol; Clofibrate; Colestipol; Drug Therapy, Combination; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; Liver; Male; Middle Aged; Phytosterols; Polyamines; Steroids; Triglycerides | 1977 |
The analysis of the two-period repeated measurements crossover design with application to clinical trials.
Topics: Analysis of Variance; Clofibrate; Colestipol; Griseofulvin; Humans; Hypercholesterolemia; Male; Research | 1977 |
Hypolipidemic agents and gallstones.
Topics: Cholelithiasis; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Polyamines | 1977 |
[Drug treatment of hyperlipoproteinemias].
Topics: Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Erectile Dysfunction; Female; Humans; Hyperlipidemias; Male; Nicotinic Acids | 1977 |
Drug therapy of hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Drug Therapy, Combination; Humans; Hyperlipidemias; Nicotinic Acids; Sitosterols | 1976 |
Effects of colestipol hydrochloride on drug absorption in the rat II.
Topics: Animals; Cellulose; Chlorpromazine; Cholestyramine Resin; Clofibrate; Colestipol; Digitoxin; Digoxin; Hydrochlorothiazide; Intestinal Absorption; Male; Nicotinic Acids; Pharmaceutical Preparations; Phenobarbital; Polyamines; Rats; Tetracycline; Warfarin | 1976 |
Plasma squalene as an index of cholesterol synthesis.
Topics: Adult; Cholesterol; Cholesterol, Dietary; Clofibrate; Colestipol; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Squalene | 1975 |
Drug treatment of hyperlipidemia.
Topics: Aminosalicylic Acids; Anabolic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Estrogens; Halofenate; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids; Progesterone; Sitosterols | 1976 |
Choice of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Lovastatin; Neomycin; Niacin; Probucol | 1991 |
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.
Topics: Adult; Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Colestipol; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Probucol | 1991 |
Noninvasive assessment of lipid disposition in treated and untreated atherosclerotic rabbits.
Topics: Animals; Arteriosclerosis; Cholesterol Esters; Cholesterol, Dietary; Clofibrate; Colestipol; Female; Iodine Radioisotopes; Polyamines; Rabbits; Radionuclide Imaging | 1989 |
Medical management of hyperlipidemia and the role of probucol.
Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pentanoic Acids; Phenols; Probucol; Risk | 1986 |
Rational drug therapy of the hyperlipoproteinemias, Part II.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol | 1986 |
Current pharmacologic treatment of elevated serum cholesterol.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides | 1987 |
Lipid-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides | 1985 |
Carotenoids and vitamin A: the effect of hypocholesterolemic agents on serum levels.
Topics: Adult; Analysis of Variance; Anticholesteremic Agents; Carotenoids; Cellulose; Cholesterol, LDL; Clofibrate; Colestipol; Humans; Hyperlipoproteinemia Type II; Middle Aged; Vitamin A | 1985 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis | 1985 |
Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
Topics: Adult; Body Weight; Cholesterol; Clofibrate; Colestipol; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type III; Lipids; Lipoproteins; Male; Middle Aged; Polyamines; Triglycerides | 1985 |
Alterations in human serum alkaline phosphatase and its isoenzymes by hypolipidemic agents: colestipol and clofibrate.
Topics: Adult; Alkaline Phosphatase; Clofibrate; Colestipol; gamma-Glutamyltransferase; Humans; Isoenzymes; Middle Aged; Polyamines | 1983 |
Plasma and lipoprotein lipid responses to four hypolipid drugs.
Topics: Adult; Aged; Aminosalicylic Acid; Ascorbic Acid; Cholesterol; Clofibrate; Colestipol; Female; Humans; Hypolipidemic Agents; Lipids; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Oxandrolone; Triglycerides | 1984 |
[Lipid lowering treatment and regression of arteriosclerosis (author's transl)].
Topics: Animals; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Clofibrate; Colestipol; Coronary Disease; Haplorhini; Humans; Nicotinic Acids | 1980 |
[Treatment of coronary heart disease with diet and lipid-reducing agents].
Topics: Adolescent; Adult; Child; Cholestyramine Resin; Clofibrate; Clofibric Acid; Colestipol; Coronary Disease; Dextrothyroxine; Humans; Hypolipidemic Agents; Nicotinic Acids; Risk | 1982 |
Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Colestipol; Dose-Response Relationship, Drug; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Polyamines; Triglycerides | 1981 |
Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Colestipol; Drug Interactions; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Polyamines; Triglycerides | 1981 |
Management of the hyperlipidaemias.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Female; Humans; Hyperlipidemias; Nicotinic Acids | 1980 |
Lipid-lowering drugs.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hypolipidemic Agents; Neomycin; Nicotinic Acids; Probucol | 1980 |
Drug treatment of hyperlipidemia.
Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hyperlipidemias; Middle Aged; Neomycin; Nicotinic Acids; Probucol | 1980 |
Choice of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol | 1993 |